SCHEMBL17876191

SCHEMBL17876191

CC1(C)Oc2ccc(-c3ccc4oc5ccccc5c4c3)cc2-c2cc(-c3cccc4c3oc3ccccc34)ccc2O1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.52
GGPS1 O95749 1/20 0.40
PRKDC P78527 4/20 0.40
HSP90AA1 P07900 1/20 0.38
HSP90AB1 P08238 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CYP2C19 P33261 2/20 0.38
PTGES2 Q9H7Z7 1/20 0.38
NPC1 O15118 2/20 0.36
MAPT P10636 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PGR P06401 2/20 0.35
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
PLA2G10 O15496 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876137 0.95 ALOX5 (0.48) ALOX5GGPS1PRKDCHSP90AA1HSP90AB1
SCHEMBL17876126 0.95 ALOX5 (0.48) ALOX5GGPS1PRKDCHSP90AA1HSP90AB1
SCHEMBL17876188 0.94 ALOX5 (0.58) ALOX5GGPS1PRKDCMEN1KMT2A
SCHEMBL17876189 0.93 ALOX5 (0.52) ALOX5GGPS1PRKDCMEN1KMT2A
SCHEMBL17876190 0.90 ALOX5 (0.52) ALOX5GGPS1PRKDCHSP90AA1HSP90AB1
SCHEMBL17876204 0.90 MAPT (0.44) ALOX5HSP90AA1HSP90AB1MEN1KMT2A
SCHEMBL17876192 0.89 ALOX5 (0.51) ALOX5GGPS1PRKDCMEN1KMT2A
SCHEMBL17876202 0.89 HSP90AA1 (0.39) ALOX5HSP90AA1HSP90AB1MEN1KMT2A
SCHEMBL17876127 0.89 ALOX5 (0.53) ALOX5GGPS1PRKDCMEN1KMT2A
SCHEMBL17876145 0.89 ALOX5 (0.48) ALOX5GGPS1PRKDCMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 ALOX5 3059/4885GGPS1 1622/4885PRKDC 4858/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 ALOX5 3059/4885GGPS1 1622/4885PRKDC 4858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.